| Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442) |
|---|
| 05/20/2009 | EP2059514A2 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis |
| 05/14/2009 | US20090124787 Method for Producing Polyhydroxyalkanoates |
| 05/14/2009 | US20090124681 Beta-lactone compounds |
| 05/13/2009 | EP1562927B1 Thio-analogues of paclitaxel and intermediates thereof |
| 05/07/2009 | WO2009059046A1 Beta-lactone compounds |
| 05/07/2009 | WO2009006590A9 Docetaxel process and polymorphs |
| 05/07/2009 | US20090118355 Fluorotaxoids |
| 05/07/2009 | CA2704462A1 Beta-lactone compounds |
| 05/07/2009 | CA2703217A1 Antidiabetic tricyclic compounds |
| 05/06/2009 | EP2054399A1 Method for the production of oxetane group-containing (meth)acrylates |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/05/2009 | US7528130 Cytotoxic agents comprising taxanes and their therapeutic use |
| 04/30/2009 | WO2009053482A2 Activated methylene reagents and curable compositions prepared therefrom |
| 04/30/2009 | WO2008149321A3 Process for the preparation of orlistat |
| 04/30/2009 | WO2007021957A3 Fluorotaxoids |
| 04/30/2009 | CA2703596A1 Activated methylene reagents and curable compositions prepared therefrom |
| 04/28/2009 | US7524869 Taxanes having a C10 ester substituent |
| 04/28/2009 | US7524610 photopolymerizable mixture of oxetane-containing monomers, photoinitiators and solvents, used to form enclosure or nozzle layers for printers or micromechanical system switches; layers having durability, heat and chemical resistance |
| 04/28/2009 | CA2472954C Aza-arylpiperazines |
| 04/23/2009 | WO2009052456A1 Film delivery system incorporating small scale actives |
| 04/23/2009 | US20090105203 Compounds for treating viral infections |
| 04/22/2009 | EP1549628B1 Method of preparing amino acid taxane derivatives and polymer conjugates containing the same |
| 04/22/2009 | CN101415697A Method for preparation of amorphous, anhydrous crystalline or hydrated crystalline docetaxel |
| 04/22/2009 | CN100479824C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 04/21/2009 | US7521569 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities |
| 04/14/2009 | CA2516811C Improved process for isolation and purification of paclitaxel from natural sources |
| 04/08/2009 | EP1694660B1 Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions |
| 04/07/2009 | CA2430814C A process for the preparation of paclitaxel |
| 04/02/2009 | WO2009040829A1 A novel process for the preparation of docetaxel |
| 04/02/2009 | WO2009040827A1 A process for obtaining tetrahydrolipstatin |
| 04/01/2009 | EP1392669B1 Chromatographic separation method of paclitaxel and cephalomannin |
| 04/01/2009 | CN101397284A Method for extracting and separating paclitaxel and taxones compounds from yew |
| 03/31/2009 | US7511160 reacting a 2-deoxy-aldohexose with sulfuric acid, to form 5-hydroxyethylfuranone isomers |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | CN101395115A Preparation of alkyl ketene dimers |
| 03/25/2009 | CN101391995A Water-soluble paclitaxel ester compounds containing 1,2,3-triazole and preparation method |
| 03/25/2009 | CN101391989A Method for preparing polyhydroxy taxone and paclitaxel |
| 03/25/2009 | CN100471845C C 10 ester substituted taxadane |
| 03/24/2009 | US7507842 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
| 03/19/2009 | US20090076127 Deuterium-enriched larotaxel |
| 03/19/2009 | US20090076062 Organic Compounds |
| 03/19/2009 | US20090074830 Anti-angiogenic compositions and methods of use |
| 03/18/2009 | CN101386874A Two-liquid phase fermentation method for improving paclitaxel yield from fungi |
| 03/18/2009 | CN101386819A Saprophytic fungus for producing paclitaxel and method for producing paclitaxel using thereof |
| 03/18/2009 | CN101386607A Taxane derivatives, preparation method and applications thereof |
| 03/12/2009 | WO2009030098A1 A cellulosimicrobium cellulans, its hydrolase and in the use of transformation of taxanes |
| 03/12/2009 | WO2009006590A3 Docetaxel process and polymorphs |
| 03/12/2009 | US20090069410 Deuterium-enriched paclitaxel |
| 03/12/2009 | US20090069409 Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions |
| 03/11/2009 | EP1620417B1 Oxetane compounds containing styrenic functionality |
| 03/11/2009 | CN101384574A Adamantane derivative, composition comprising the derivative, and optical and electronic member using the composition |
| 03/05/2009 | WO2009006431A3 Biologically active aphrocallistin compounds |
| 03/05/2009 | US20090062481 Adamantane derivative, composition comprising the derivative, and optical and electronic member using the composition |
| 03/05/2009 | US20090062376 Preparation of Taxanes From 9-Dihydro-13-Acetylbaccatin III |
| 03/04/2009 | EP2030972A1 3-ethyloxethane compound having hydroxyl group and method for producing the same |
| 03/04/2009 | EP2029563A1 Semi-synthetic route for the preparation of paclitaxel, docetaxel and 10-deacetylbaccatin iii from 9-dihydro-13-acetylbaccatin iii |
| 03/04/2009 | CN100465170C A preparation method of C7, C10 substituted 1-dehydroxy baccatin VI derivatives |
| 03/03/2009 | US7498452 Taxane derivatives functionalized at the 14-position and a process for the preparation thereof |
| 03/03/2009 | US7498450 Hydrogenation of dicarboxylic acids to form diols, cyclic ethers and lactones in the presence of an aqueous solution of a ruthenium, rhodium, iron, osmium or palladium compound and a phosphine, preferably tridentate facially capped phosphines (tris-1,1,1-(diarylphosphinomethyl)alkane) |
| 02/26/2009 | WO2009023967A1 Process for converting 9-dihydro-13-acetylbaccatin iii into docetaxel or paclitaxel |
| 02/26/2009 | CA2696856A1 Process for converting 9-dihydro-13-acetylbaccatin iii into docetaxel or paclitaxel |
| 02/24/2009 | US7495114 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/18/2009 | CN101370798A Novel compounds for forming taxone, method and use thereof |
| 02/12/2009 | US20090042922 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis |
| 02/11/2009 | CN101365691A Dioxetane compound, cationically polymerizable composition, optical film and liquid crystal display unit |
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |
| 02/04/2009 | EP2020407A1 2-oxetanone derivative and process for production thereof |
| 01/29/2009 | US20090028904 Novel cochleate formulations |
| 01/28/2009 | EP2018858A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic trioxide |
| 01/28/2009 | EP1778660B1 Process for the separation of paclitaxel and cephalomannin |
| 01/28/2009 | CN101353334A Method for preparing docetaxel |
| 01/28/2009 | CN101353333A 10- deacetylate-9(R)-hydrogenization-1-deoxypaclitaxel analogue and preparation thereof |
| 01/27/2009 | CA2361187C A process for the preparation of taxanes from 10-deacetylbaccatin iii |
| 01/15/2009 | WO2008115805A3 Cobalamin taxane bioconjugates |
| 01/15/2009 | US20090018353 Method for preparation of amorphous, anhydrous crystalline or hydrated crystalline docetaxel |
| 01/14/2009 | EP2012749A2 Pharmaceutical composition containing a taxane derivative, destined for the preparation of an infusion solution, method of preparation thereof and use thereof |
| 01/14/2009 | CN101343262A Process for preparing docetaxel |
| 01/13/2009 | US7476669 Immobilization of taxane; anticancer, antitumor agents |
| 01/13/2009 | US7476647 1,5-dioxa-3-methyl-16-cyclohexadecanone; original odor characteristics, diffuses extremely well and is suitable for use as a fragrance, for example in cosmetic preparations, technical products or in alcoholic perfumery. |
| 01/13/2009 | CA2386772C Pentacyclic taxane compound |
| 01/08/2009 | WO2009006590A2 Docetaxel process and polymorphs |
| 01/08/2009 | WO2009004188A2 Direct dissolution of docetaxel in a solvent in polysorbate 80 |
| 01/07/2009 | EP2011789A1 Compositions containing oxetane compounds for use in semiconductor packaging |
| 01/07/2009 | CN101337951A Method for preparing docetaxel anhydrous crystal |
| 01/07/2009 | CN100448859C Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins |
| 01/07/2009 | CN100448858C Method in internal sizing of liquid packaging board and internal size |
| 01/06/2009 | US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 01/06/2009 | US7473788 e.g. 10-O-(trifluoromethyl-3H-diazirine)benzyl ginkgolide; platelet-activating factor receptor (PAFR) inhibitor; neurodegenerative disorders, cognition activator; containing photoactivatable, fluorescent, or radioactive moiety; |
| 01/06/2009 | CA2340921C Use of taxanes to treat brain cancer |
| 12/31/2008 | EP2007744A1 Thermal extraction method and product |
| 12/31/2008 | EP2007739A2 A convergent process for the synthesis of taxane derivatives |
| 12/25/2008 | US20080319049 Compounds For the Treatment of Metabolic Disorders |
| 12/24/2008 | CN101328159A Taxone precursor anti-cancer drugs, medicinal composition and use thereof |
| 12/24/2008 | CN101328158A Method for synthesizing butyl oxide linkage |
| 12/23/2008 | US7468462 Modulate activity of Nuclear Retinoid receptors; regulating cell differentiation and cell cycle processes and cellular signaling processes regulated by thyroid hormone, vitamin D, all-trans retinoic acid; 2-[6-(3-Adamantan-1-yl-4-methoxyphenyl)-naphthalen-2-yl]-3-hydroxy-cyclopent-2-enone |
| 12/17/2008 | EP2003124A1 Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III |
| 12/17/2008 | EP2002825A1 Pharmaceutical compositions comprising orlistat |
| 12/17/2008 | CN101323620A Taxane derivative 7,9,9,10- diacetonol-10-deacetylbaccatin III |
| 12/16/2008 | US7465563 Enzymatic process for the manufacture of L-ascorbic acid and D-erythorbic acid |
| 12/11/2008 | US20080305101 Methods and Compositions Related to Clot Binding Compounds |